Artículos personalizados con papel y vinil.
Employees: 11-50
Total raised: $120.2M
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| - | Wellington... | wellington... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.10.2021 | Series B | $75.36M | - |
| 04.11.2016 | Series A | $44.84M | - |
Mentions in press and media 8
| Date | Title | Description |
| 06.10.2021 | iOmx raises 65 million euros | Martinsried-based iOmx Therapeutics AG has closed a 65 million euros Series B financing round. The financing was led by Athos Service GmbH - the family office of the Strüngmann family - and MIG Capital AG, with participation from existing i... |
| 06.10.2021 | Germany's iOmx Therapeutics raises €65M | Athos Service and MIG Capital have co-led a €65 million Series B for drug discovery startup iOmx Therapeutics, with participation from existing investors Wellington Partners, Sofinnova Partners and M Ventures. Munich-based iOmx develops can... |
| 06.10.2021 | iOmx Therapeutics raises EUR 65 million in Series B round | iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on next generation immune checkpoint targets, today announced the closing of a Series B round totaling EUR 65 million. |
| 05.10.2021 | PRESS RELEASE : iOmx Therapeutics raises EUR 65 million in Series B round | DGAP-News: iOmx Therapeutics AG / Key word(s): Financing iOmx Therapeutics raises EUR 65 million in Series B round 2021-10-05 / 10:30 The issuer is solely responsible for the content of this announcement. -----------------------------------... |
| 05.10.2021 | IOmx Therapeutics : raises EUR 65 million in Series B round | DGAP-News: iOmx Therapeutics AG / Key word(s): Financing iOmx Therapeutics raises EUR 65 million in Series B round 05.10.2021 / 10:30 The issuer is solely responsible for the content of this announcement. iOmx Therapeutics raises EUR 65 mil... |
| 04.11.2016 | iOmx Therapeutics Raises €40M in Series A Funding | iOmx Therapeutics AG, a Martinsried, near Munich, Germany-based biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, recently closed a €40m Series A financing round. The round was co-led by MPM ... |
| 22.09.2016 | Wellington invests in iOmx €40m Series A | iOmx Therapeutics raises EUR 40 million in Series A round led by MPM Capital, Sofinnova Partners, Wellington Partners and Merck Ventures |
| 22.09.2016 | iOmx Therapeutics Raises EUR 40 Million in Series A round | - |